On-site medical gas production plant and associated operating method

Patent metadata

Field	Value
Publication number	US-9889268-B2
Application number	US-201715596253-A
Country	US
Kind code	B2
Filing date	May 16, 2017
Priority date	Sep 27, 2013
Publication date	Feb 13, 2018
Grant date	Feb 13, 2018

Abstract

The invention relates to an on-site medical gas production plant ( 100 ) comprising a unit ( 50 ) for purifying gas, such as air, a first compartment (A) for storing purified gas, and a main gas line ( 10 ) fluidically connecting the gas purification unit ( 50 ) to the said first storage compartment (A). It furthermore comprises a three-way actuated valve (VA) arranged on the main gas line ( 10 ) upstream of the first storage compartment (A), and furthermore connected to the atmosphere (at 12 ) via a vent line ( 11 ), as well as an operating device ( 4 ) which controls at least the three-way actuated valve (VA), and at least a first gas analysis device (D 1 ) of which a first measurement line ( 29 ) is fluidically connected (at 28 ) to the main line ( 10 ), upstream of the three-way actuated valve (VA), and which is electrically connected to the said operating device ( 4 ).

First claim

What is claimed is:

1. A method for operating an on-site medical gas production plant ( 100 ), the plant comprising:
a synthetic air production unit ( 50 ) configured to produce a mixture comprising nitrogen and oxygen which is medically suitable for respiration by patients in place of or in addition to air,
a first compartment (A) for storing the purified gas, and
a main gas line ( 10 ) fluidically connecting the synthetic air production unit ( 50 ) to the first storage compartment (A) so as to supply the said first storage compartment (A) with the synthetic air coming from the synthetic air production unit ( 50 ),
wherein the main gas line furthermore comprises:
an actuated valve (VA) arranged on the main gas line ( 10 ) between the synthetic air production unit ( 50 ) and the first storage compartment (A), and furthermore connected to the atmosphere (at 12 ) via a vent line ( 11 ),
an operating device ( 4 ) which controls the at least one actuated valve (VA),
at least a first gas analysis device (D 1 ) of which a first measurement line ( 29 ) is fluidically connected (at 28 ) to the main line ( 10 ), upstream of the actuated valve (VA), and which is electrically connected to the operating device ( 4 ),
and in which the operating device ( 4 ) is designed and adapted to act on the actuated valve (VA) in response to a signal received from the gas analysis device (D 1 ), so as to divert a gas present in the main pipe ( 10 ) to pass to the vent line ( 11 ) when the signal received from the gas analysis device (D 1 ) corresponds to a contamination signal based on an analysis of the gas in the main pipe ( 10 ), and simultaneously to prevent the gas present in the main pipe ( 10 ) from being sent to the said first storage compartment (A);

the method comprising the steps of:
a) producing a synthetic air comprising nitrogen and oxygen which is medically suitable for respiration by patients in place of or in addition to air,
b) transporting the synthetic air obtained in step a) in a main gas pipe ( 10 ),
c) storing at least a part of the synthetic air in a first compartment (A) for storing gas supplied by the main gas pipe ( 10 ),
d) determining in the main gas pipe ( 10 ), upstream of the first storage compartment (A), an impurity level of at least one given impurity in the synthetic air produced in step a) based on the signal received from the gas analysis device (D 1 ) corresponding to the contamination signal, and
e) controlling an actuated valve (VA) arranged on the main gas line ( 10 ) upstream of the first storage compartment (A), and furthermore connected to the atmosphere (at 12 ) via a vent line ( 11 ), so as to divert the synthetic air present in the main pipe ( 10 ), upstream of the actuated valve (VA), to the vent line ( 11 ) when the impurity level measured in step d) is greater than or equal to a preset threshold level,
wherein the contamination signal from the gas analysis device (D 1 ) corresponds to a measurement for the level of NOx, SOx, COx, water vapour, hydrocarbon vapours, carbon monoxide, carbon dioxide, nitric oxide, nitrogen dioxide, sulphur dioxide, and combinations thereof.

2. The method according to claim 1 , wherein in step e), the synthetic air present in the main pipe ( 10 ), upstream of the actuated valve (VA), is diverted to the vent line ( 11 ) and synthetic air is simultaneously stopped from being sent to the first storage compartment (A), when the impurity level measured in step d) is greater than or equal to a preset threshold level.

3. The method according to claim 2 , wherein:
in step a), the synthetic air production unit ( 50 ) comprises at least two adsorbers ( 1 , 2 ) operating alternately, and
when an impurity level greater than or equal to a preset threshold level is determined in the gas produced by one of the adsorbers, the production of the gas by the adsorber is stopped and the production of purified gas by another of the adsorber(s) is started.

4. The method according to claim 2 , wherein a gaseous flushing step of the main pipe ( 10 ) containing an impurity level greater than or equal to the preset threshold level with synthetic air is carried out and the gas flow thus generated is discharged to the atmosphere via the vent line ( 11 ).

5. The method of claim 1 , wherein the nitrogen and/or oxygen are from a less pure supply gas source to be purified by the synthetic air production unit ( 50 ) to yield a synthetic air that qualifies as is a medical air or a medical oxygen gas.

6. The method of claim 5 , wherein the synthetic medical air meets the following criteria:
19.5% to 23.5% oxygen, with predominant balance nitrogen
Carbon monoxide: <10 ppm
Carbon dioxide: <500 ppm
Nitrogen dioxide: <2.5 ppm
Nitric oxide: <2.5 ppm
Sulfur dioxide: <5 ppm.

7. The method of claim 1 , wherein the impurity or impurities are selected from NOx, SOx, COx, water vapour, hydrocarbon vapours, or combinations thereof.

8. The method of claim 5 , wherein the medical air produced contains (by volume) from 20.4% to 21.4% oxygen, at most 500 ppm CO 2 , at most 5 ppm CO, at most 1 ppm SO 2 , at most 2 ppm NO and NO 2 , at most 67 ppm water, at most 0.1 mg/m 3 oil, and nitrogen.

9. The method of claim 5 , wherein in step d), a gas analysis device (D 1 ) determines the impurity level in the gas in the main gas pipe ( 10 ).

10. The method of claim 9 , wherein in step e), an operating device ( 4 ) controls the actuated valve (VA), the operating device ( 4 ) acting in response to the measurements taken by the gas analysis device (D 1 ).

11. The method of claim 10 , wherein the operating device ( 4 ) monitors the signal received ( 210 ) from the gas analysis device (D 1 ) during a first defined period of a purge operation to determine if the contamination signal persists for longer than a specified period of time and wherein, if the contamination signal persists for less than the specified period, the operating device ( 4 ) closes a vent line ( 11 ) actuated valve (VB) to end the purge operation and reopens the main line ( 10 ) actuated valve (VA) to resume delivery of gas from the gas purification unit ( 50 ) to the first storage compartment (A).

Assignees

• Air Liquide
• Lair Liquide Soc Pour Letude Et Lexploitation Des Procedes Georges Claude

Inventors

• Edwards Paul

Classifications

• B01D53/0454 Primary

  Controlling adsorption (controlling temperature swing adsorption B01D53/0462, controlling pressure swing adsorption B01D53/047) · CPC title

• B01D2257/502

  Carbon monoxide · CPC title

• A61M2205/3327

  Measuring · CPC title

• A61M16/1005 Primary

  with O2 features or with parameter measurement · CPC title

• B01D2258/06

  Polluted air · CPC title